The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial

OBJECTIVE: N-acetylcysteine (NAC) is a novel therapeutic agent with multiple mechanisms of action in the central nervous system and a favourable side effect profile. Clinical evidence indicates that adjunctive NAC may reduce the severity of depressive symptoms in individuals with major depressive di...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Samantha E., Skvarc, David R., Mohebbi, Mohammadreza, Camfield, David, Byrne, Linda K., Turner, Alyna, Ashton, Melanie M., Berk, Michael, Dodd, Seetal, Malhi, Gin S., Cotton, Sue M., Bush, Ashley I., Dean, Olivia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157003/
https://www.ncbi.nlm.nih.gov/pubmed/37119225
http://dx.doi.org/10.9758/cpn.2023.21.2.320

Ejemplares similares

Ejemplares similares